Bristol Myers Squibb to Take Part in Goldman Sachs 42nd Annual Global Healthcare Conference

- June 4th, 2021

Bristol Myers Squibb today announced that the company will participate in a fireside chat at the Goldman Sachs 42 nd Annual Global Healthcare Virtual Conference, which will be webcast on Thursday, June 10, 2021. Chris Boerner, Ph.D., Executive Vice President, Chief Commercialization Officer and Samit Hirawat, M.D., Executive Vice President, Chief Medical Officer, Global Drug Development will answer questions about …

Bristol Myers Squibb (NYSE: BMY) today announced that the company will participate in a fireside chat at the Goldman Sachs 42 nd Annual Global Healthcare Virtual Conference, which will be webcast on Thursday, June 10, 2021. Chris Boerner, Ph.D., Executive Vice President, Chief Commercialization Officer and Samit Hirawat, M.D., Executive Vice President, Chief Medical Officer, Global Drug Development , will answer questions about the company at 9:40 a.m. ET.

Investors and the general public are invited to listen to a live webcast of the session at http://investor.bms.com . An archived edition of the session will be available later that day.

About Bristol Myers Squibb

Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn , Twitter , YouTube , Facebook , and Instagram .

CorporateFinancial-News

Bristol Myers Squibb

Media:
media@bms.com

Investor Relations:

Tim Power, 609-252-7509, timothy.power@bms.com

Nina Goworek, 908-673-9711, nina.goworek@bms.com

News Provided by Business Wire via QuoteMedia

  Life Science and Healthcare Investing report cover

Life Science and Healthcare Investing in 2021

 
The life science and healthcare market is a booming, multi-billion dollar industry. Read our 2021 life science outlook report!
 

Get the latest Biotech Investing stock information

Get the latest information about companies associated with Biotech Investing Delivered directly to your inbox.

Biotech Investing

Select None
Select All

Leave a Reply